[go: up one dir, main page]

ZA811729B - 3,8-dialkyixanthines, their preparation and use - Google Patents

3,8-dialkyixanthines, their preparation and use

Info

Publication number
ZA811729B
ZA811729B ZA00811729A ZA811729A ZA811729B ZA 811729 B ZA811729 B ZA 811729B ZA 00811729 A ZA00811729 A ZA 00811729A ZA 811729 A ZA811729 A ZA 811729A ZA 811729 B ZA811729 B ZA 811729B
Authority
ZA
South Africa
Prior art keywords
sup
butyl
ethyl
compounds
methylbutyl
Prior art date
Application number
ZA00811729A
Other languages
English (en)
Inventor
P Kjellin
C Persson
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of ZA811729B publication Critical patent/ZA811729B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA00811729A 1980-04-18 1981-03-16 3,8-dialkyixanthines, their preparation and use ZA811729B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8002910A SE8002910L (sv) 1980-04-18 1980-04-18 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar

Publications (1)

Publication Number Publication Date
ZA811729B true ZA811729B (en) 1982-04-28

Family

ID=20340763

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00811729A ZA811729B (en) 1980-04-18 1981-03-16 3,8-dialkyixanthines, their preparation and use

Country Status (21)

Country Link
US (1) US4546182A (pt)
EP (1) EP0038784B1 (pt)
JP (1) JPS56166191A (pt)
AT (1) ATE10099T1 (pt)
AU (1) AU543122B2 (pt)
CA (1) CA1156229A (pt)
DD (1) DD158400A5 (pt)
DE (1) DE3166893D1 (pt)
DK (1) DK151631B (pt)
ES (1) ES501400A0 (pt)
FI (1) FI69465C (pt)
GR (1) GR82347B (pt)
HU (1) HU185254B (pt)
IE (1) IE51106B1 (pt)
NO (1) NO811161L (pt)
NZ (1) NZ196829A (pt)
PH (1) PH16264A (pt)
PL (1) PL134762B1 (pt)
PT (1) PT72881B (pt)
SE (1) SE8002910L (pt)
ZA (1) ZA811729B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines
US4710503A (en) * 1985-02-07 1987-12-01 Euroceltique S.A. 6-thioxanthine derivatives
GB8618931D0 (en) * 1986-08-02 1986-09-10 Euro Celtique Sa 6-thioxanthines
US5298508A (en) * 1988-07-19 1994-03-29 The United States Of America As Represented By The Department Of Health And Human Services Irreversible inhibitors of adenosine receptors
JP2843634B2 (ja) * 1989-03-06 1999-01-06 協和醗酵工業株式会社 キサンチン誘導体
IT1229195B (it) * 1989-03-10 1991-07-25 Poli Ind Chimica Spa Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche.
AU5436790A (en) * 1989-04-19 1990-11-16 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Sulfer-containing xanthine derivatives as adenosin antagonists
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
US5366977A (en) * 1992-09-29 1994-11-22 The United States Of America, As Represented By The Department Of Health And Human Services Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners
DE4311538C1 (de) * 1993-04-07 1994-10-06 Boehringer Ingelheim Kg Verfahren zur Herstellung von 1,3-Dimethyl-4,5-diaminouracil
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
WO1997037667A1 (en) 1996-04-10 1997-10-16 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of an a1 adenosine receptor agonist to treat cerebral ischaemia

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53890B2 (pt) * 1972-04-22 1978-01-12
US4089959A (en) * 1976-03-31 1978-05-16 Cooper Laboratories, Inc. Long-acting xanthine bronchodilators and antiallergy agents
CA1077932A (en) * 1976-03-31 1980-05-20 Berlex Laboratories, Inc. Xanthine compounds and method of treating bronchospastic and allergic diseases
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
SE7810946L (sv) * 1978-10-20 1980-04-21 Draco Ab Metod att behandla kronisk obstruktiv luftvegssjukdom
SE7810947L (sv) * 1978-10-20 1980-04-21 Draco Ab 3-alkylxanthines

Also Published As

Publication number Publication date
DD158400A5 (de) 1983-01-12
NZ196829A (en) 1984-12-14
ES8203088A1 (es) 1982-02-16
JPS56166191A (en) 1981-12-21
EP0038784A3 (en) 1982-01-20
PH16264A (en) 1983-08-23
HU185254B (en) 1984-12-28
EP0038784A2 (en) 1981-10-28
IE51106B1 (en) 1986-10-01
FI69465B (fi) 1985-10-31
IE810796L (en) 1981-10-18
PL230737A1 (pt) 1982-03-29
SE8002910L (sv) 1981-10-19
PT72881A (en) 1981-05-01
PT72881B (en) 1983-03-29
DK151631B (da) 1987-12-21
FI69465C (fi) 1986-02-10
DE3166893D1 (en) 1984-12-06
DK168281A (da) 1981-10-19
AU6955581A (en) 1981-10-22
GR82347B (pt) 1984-12-13
ES501400A0 (es) 1982-02-16
FI811212L (fi) 1981-10-19
CA1156229A (en) 1983-11-01
US4546182A (en) 1985-10-08
NO811161L (no) 1981-10-19
PL134762B1 (en) 1985-09-30
ATE10099T1 (de) 1984-11-15
EP0038784B1 (en) 1984-10-31
AU543122B2 (en) 1985-04-04

Similar Documents

Publication Publication Date Title
DE3260529D1 (en) Therapeutically useful 1-alkyl-2-aminotetralin derivatives
ZA811729B (en) 3,8-dialkyixanthines, their preparation and use
GR3019388T3 (en) The use of buspirone for preparing a pharmaceutical composition for the treatment of alcohol abuse
EP0011609A3 (en) Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives
NZ214653A (en) 6-thioxanthine derivatives and pharmaceutical compositions
EP0376899A3 (en) Use of L-carnitine derivatives for the manufacture of a medicament for the therapeutical treatment of peripheral neuropathies
EP0138344A3 (en) Pyridazinones as beta-adrenoceptor antagonists
ES8800161A1 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
EP0150505A3 (en) 3-indolecarboxamide compounds
AR245125A1 (es) Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos y sus sales de adicion de acidos farmaceuticamente aceptables.
HUT37381A (en) Process for producing new cycloaliphatic compounds of antiandrogenic activity
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
DE3277971D1 (en) Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use
CA1251463A (en) SYNTHESIS OF HYDROXYL ANALOGS OR DERIVATIVES OF METHIONINE, AND OF THEIR ESTERS; SYNTHESIS OF 1-ACYLOXY-4-HYDROCARBYLTHIOPROPENE; PRODUCTS OBTAINED
ES8304924A1 (es) Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama.
JPS6463520A (en) Prolactin secretion inhibitor
DE3261643D1 (en) New peptide, process for preparation thereof and use thereof
ES8502128A1 (es) Procedimiento para la preparacion de derivados de 6 -metilprednisolona
JPS5420122A (en) Antitumor preparation
DE3065093D1 (en) Therapeutic composition based on imidazoles, especially for the treatment of thromboses; imidazoles and process for their preparation
AU2564188A (en) Agent for the treatment of heart disease
ES8507520A1 (es) Un procedimiento para la preparacion de nuevos compuestos de b-lactama
KR830005222A (ko) 만성 폐쇄성 기도 질병 및 심장혈관 질병치료용의 3,8-디알릴크산틴의 제조방법 및 그 조성물과 치료방법
JPS53132597A (en) Cytidylic acid derivative and its preparation